Based on the available information, there is some potential for Cosentyx use to affect your body's response to vaccines.

Cosentyx, also known as secukinumab, is a biologic medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. Biologic medications like Cosentyx work by targeting specific proteins in the immune system, which can potentially impact the body's immune response [2].

A study published in the Journal of Allergy and Clinical Immunology found that biologic medications, including secukinumab, may affect the immune response to vaccines [3]. Specifically, the study found that patients taking biologics had a reduced response to pneumococcal and tetanus toxoid vaccines compared to those not taking biologics [3].

However, it's important to note that the impact of Cosentyx on vaccine response may vary depending on several factors, including the type of vaccine, the timing of vaccine administration, and the individual patient's immune status [2].

The manufacturer of Cosentyx, Novartis, acknowledges the potential impact of Cosentyx on vaccine response and recommends that patients discuss their vaccination history and future vaccination plans with their healthcare provider [4].

In summary, based on the available information, Cosentyx use may affect your body's response to vaccines. Patients taking Cosentyx should discuss their vaccination history and future vaccination plans with their healthcare provider.

Sources:

[1] <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>

[2] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>

[3] <https://www.jacionline.org/article/S0091-6749(17)31132-3/fulltext>

[4] <https://www.cosentyx.com/all/covid19>